AppointmentsNew Board Appointments At CBD Firm Voyager

New Board Appointments At CBD Firm Voyager


SCOTTISH CBD firm Voyager has announced three key appointments as it targets fresh distribution channels for its popular range of products and prepares to list on the pan-European Aquis Growth Market in June.

The Perth-based firm set-up in November 2020 by former Zoetic International CEO Nick Tulloch, has appointed two new non-executive directors and a head of sales.

Jill Overland and Nikki Cooper will shortly join the board, while Mark Underwood as head of sales has been charged with finding new outlets for Voyager’s CBD and hemp seed oil products, which are available through its own online portal and more than 20 third-party websites.

Nikki Cooper

Ms Overland has more than 25 years’ experience working in senior finance roles and is currently responsible for finance and corporate services at Cuadrilla. 

Ms Cooper is a qualified solicitor and chartered company secretary, whose career to date has spanned multiple roles, including as a general counsel at Ora Capital Partners, and in corporate finance at N+1 Brewin. 

She also founded her own health supplement brand, Inner Me Limited, following her diagnosis with multiple sclerosis in 2009. The brand successfully gained entry into major retailers, including Boots, Holland and Barrett, Selfridges, Ocado, and on the free-to-air television shopping channel QVC.

Mr Underwood has spent most of his career implementing sales strategies for several blue-chip companies, and was most recently UK sales director in a firm specialising in the CBD market  in the health and wellbeing industry. 

Voyager chairman, Eric Boyle, said the appointments “reflect our robust approach to assurance and compliance as the strong foundations upon which we are building the brand and the business.”

In February, Voyager raised £874,000 through an oversubscribed crowdfunding campaign on Seedrs, and a further £741,000 in April through a private fundraise, including a commitment of £100,000 from Greencare Capital plc, the Aquis-listed investment company focused on medicinal cannabis and related areas.

Jill Overland

Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.


Please enter your comment!
Please enter your name here

Latest news

High-Profile Director Quits Oxford Cannabinoid Technologies Board Following Chairman’s Recent Departure

Oxford Cannabinoid Technologies (OCT) has seen its second senior departure in under a month as it begins to recover...

Columbia Care Platinum Joins Forces With Poppy Jamie

Leading organic, vegan and regeneratively-farmed, plant-based CBD brand, Columbia Care Platinum(, announces it has teamed up with Poppy Jamie, mental wellbeing...

InterCure Announces European Expansion with International Cannabis Brand Cookies

InterCure Ltd. today announced its international expansion into Europe through a partnership with iconic cannabis brand Cookies. The parties entered...

Groups From 56 Countries Ask UN To Ensure Secretive ‘Cannabis Initiative’ Is Open To Public Scrutiny

ONE year on from the formal recognition of the potential for cannabis as a medicine almost 200 global advocacy...

The New Common Agricultural Policy Has Been Adopted And the Maximum THC Level on the Field Has Been Restored to 0.3%

It was in October 2020 when we announced that the European Parliament had voted in favour of restoring the...

European Medical Cannabis Tech Accelerator Opens Call for Submissions

The first and only hybrid tech accelerator in Europe dedicated to the medical cannabis industry offers €100,000 grant to early-stage startups from around the world.

Must read

High-Profile Director Quits Oxford Cannabinoid Technologies Board Following Chairman’s Recent Departure

Oxford Cannabinoid Technologies (OCT) has seen its second senior...

You might also likeRELATED
Recommended to you